Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes

AIMS/INTRODUCTION: We investigated the difference in efficacy and safety between discontinuation and maintaining of sulfonylurea when adding a sodium–glucose cotransporter 2 inhibitor. MATERIALS AND METHODS: In the present multicenter, prospective observational study, 200 patients with type 2 diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Kiyohiko, Cho, Kyu Yong, Nakamura, Akinobu, Miya, Aika, Miyoshi, Arina, Yamamoto, Chiho, Nomoto, Hiroshi, Niwa, Hirokatsu, Takahashi, Kiyohito, Manda, Naoki, Kurihara, Yoshio, Aoki, Shin, Ito, Yoichi M, Atsumi, Tatsuya, Miyoshi, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400155/
https://www.ncbi.nlm.nih.gov/pubmed/30136403
http://dx.doi.org/10.1111/jdi.12913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400155/
https://www.ncbi.nlm.nih.gov/pubmed/30136403
http://dx.doi.org/10.1111/jdi.12913

Ejemplares similares